Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
In a recent study published in the Journal of the American Heart Association, researchers evaluated the individual and combined effects ...
Research has shown that mycoprotein, which is a fungal-derived food source rich in fiber and protein, is effective in reducing ...
In a recent study published in the Journal of the Academy of Nutrition and Dietetics, researchers reviewed the effects of ...
A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal ...
A recent study published in the journal Scientific Reports assessed the associations between the change in total cholesterol (TC) levels ...
Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation, a leading research and ...
The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net